INDEX ANNOUNCEMENT S&P Dow Jones Indices Announces September 2026 Quarterly Rebalance of the S&P/ASX Indices SYDNEY, SEPTEMBER 4, 2026: S&P Dow Jones Indices announced today the changes in the S&P/ASX Indices, effective prior to the open of trading on Monday,...
S&P DJI Announces September 2026 Quarterly Rebalance
Filed with ASX · · 6 pages · English
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- Application for quotation of securities - BLS
- Appendix 4G Corporate Governance Statement
- BLS FY2027 Guidance
- BLS Investor Presentation
- BLS FY2026 Results Announcement
Later from BLS Pharmaceuticals
- Angus Walker Appointed Alternate Director to Edward Myer
- Initial Director's Interest Notice
- AGM Date and Director Nominations
- Becoming a substantial holder
- Ceasing to be a substantial holder
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals